Clinical Trials Browser

OTHER × Interventional × Interferons × Clear all

NCT07199413 2025-09-30

Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy: A Phase I Pilot Safety and Feasibility Study for Solid Tumor Patients With CNS Metastases

Phase 1 Not yet recruiting

Brain Neoplasms, Meningeal Carcinomatosis

NCT04116502 2024-11-18

MITHRIDATE

Phase 3 Recruiting

Polycythemia Vera

NCT00577993 2020-11-16

Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients

Phase 3 Completed

210 enrolled 14 charts

Lymphoma, Lymphoma, Follicular

NCT01658813 2018-03-21

5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer

Phase 2 Completed

18 enrolled 2 charts

GastrointestinalGenitourinaryThoracic

Gastrointestinal Cancer Metastatic

NCT00311558 2018-01-26

Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma

Phase 1 Terminated

DermatologicSarcoma

Melanoma, Neoplasms, Sarcoma

NCT01276730 2017-12-29

Advanced Cervical Cancer Trial in India

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00842114 2016-04-04

LNH-Pro-05

Phase 2 Completed

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT00276536 2015-10-14

IFNa

Phase 1 Completed

BreastDermatologicGenitourinaryLymphoidPlasma cellSarcoma

Breast Neoplasms, Kidney Neoplasms, Lymphoma, Melanoma, Multiple Myeloma, Sarcoma

NCT01782508 2013-02-04

A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma

Phase 2 Unknown

Melanoma

NCT00962715 2012-08-03

Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Influenza, Human, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01409187 2012-01-26

IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma

Phase 1/2 Withdrawn

Melanoma

NCT00250796 2010-01-07

Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

NCT00390897 2008-11-27

Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia

Phase 4 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00140569 2005-09-01

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

Phase 3 Completed

Lymphoma, Follicular